已收盘 02-06 16:00:00 美东时间
+1.700
+1.70%
今日重点评级关注:RBC Capital:维持Compass Pathways"跑赢大市"评级,目标价从16美元升至21美元;RBC Capital:维持GH Research"跑赢大市"评级,目标价从33美元升至40美元
01-26 14:32
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46
Morgan Stanley analyst Simeon Gutman maintains Acushnet Holdings (NYSE:GOLF) with a Equal-Weight and raises the price target from $90 to $95.
01-23 00:19
Keybanc analyst Noah Zatzkin downgrades Acushnet Holdings (NYSE:GOLF) from Overweight to Sector Weight.
01-16 19:27
今日重点评级关注:Benchmark:维持TNL Mediagene"投机性买入"评级,目标价从3.5美元升至14美元;康托·菲茨杰拉德:维持Eupraxia Pharmaceuticals"超配"评级,目标价从11美元升至19美元
01-16 10:04
Morgan Stanley analyst Simeon Gutman maintains Acushnet Holdings (NYSE:GOLF) with a Equal-Weight and raises the price target from $80 to $90.
01-15 23:29
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
2025-12-16 09:36
JP Morgan analyst Matthew Boss maintains Acushnet Holdings (NYSE:GOLF) with a Underweight and raises the price target from $67 to $74.
2025-12-16 03:03
An update from Acushnet Holdings ( ($GOLF) ) is now available. On November 12, ...
2025-11-12 21:18
Acushnet Holdings Corp (NYSE: GOLF) shares surge on strong Q3 results, beating sales estimates and raising FY outlook.
2025-11-06 01:22